PMID- 19620188 OWN - NLM STAT- MEDLINE DCOM- 20090813 LR - 20221207 IS - 1098-4275 (Electronic) IS - 0031-4005 (Linking) VI - 124 IP - 2 DP - 2009 Aug TI - Screening for type 2 diabetes in obese youth. PG - 573-9 LID - 10.1542/peds.2008-2949 [doi] AB - OBJECTIVE: To assess available blood tests as potential screening tools for impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM). METHODS: We studied 468 obese (BMI mean: 34.4 kg/m(2)) children, including a subgroup with serum fasting insulin levels of >15 microIU/mL. Fasting laboratory tests included measurements of serum glucose and insulin, hemoglobin A1c (HbA1c), and 1,5-anhydroglucitol (insulin-resistant subgroup only) levels. An oral glucose-tolerance test was performed on each patient, and 2-hour postload serum glucose and insulin levels were obtained. Fasting blood glucose (BG), Homeostasis Model of Assessment for Insulin Resistance (HOMA-IR), HbA1c, and 1,5-anhydroglucitol values were used as predictors for exceeding various 2-hour BG cut-offs. Receiver operator characteristic curves were fitted to determine area-under-the-curve values as measures of screening efficacy. RESULTS: In the insulin-resistant subgroup, 3 (2%) patients had T2DM and 23 (12%) had IGT. Optimal sensitivity and specificity to detect T2DM were, respectively, 99% and 96% at HbA1c >or= 6.0%, and 96% and 88% at 1,5-anhydroglucitol < 17.0 microg/mL, with lower values for fasting BG and the HOMA-IR. In the entire study group, 9 (2%) patients had T2DM and 44 (9%) had IGT. Optimal sensitivity and specificity to detect T2DM were, respectively, 86% and 85% at HbA1c levels of 5.7%, 88%, and 93% at a fasting BG level of 104 mg/dL, and 62% and 70% at an HOMA-IR of 7.9. CONCLUSIONS: HbA1c, 1,5-anhydroglucitol, and fasting BG levels are good predictors of T2DM in obese children, whereas HOMA-IR values are not. HbA1c and 1,5-anhydroglucitol are excellent predictors of T2DM in insulin-resistant obese children. FAU - Shah, Shuchi AU - Shah S AD - Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9063, USA. FAU - Kublaoui, Bassil M AU - Kublaoui BM FAU - Oden, Jon D AU - Oden JD FAU - White, Perrin C AU - White PC LA - eng PT - Journal Article DEP - 20090720 PL - United States TA - Pediatrics JT - Pediatrics JID - 0376422 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Insulin) RN - 0 (hemoglobin A1c protein, human) RN - 54BB3B7XMZ (1,5-anhydroglucitol) RN - 9G2MP84A8W (Deoxyglucose) SB - IM MH - Adolescent MH - Age Factors MH - Blood Glucose/metabolism MH - Body Mass Index MH - Child MH - Deoxyglucose/blood MH - Diabetes Mellitus, Type 2/blood/*diagnosis/*epidemiology MH - Female MH - Glucose Tolerance Test MH - Glycated Hemoglobin/metabolism MH - Humans MH - Hyperglycemia/blood/*diagnosis/*epidemiology MH - Insulin/blood MH - Insulin Resistance/physiology MH - Male MH - *Mass Screening MH - Obesity/blood/*epidemiology MH - Predictive Value of Tests MH - ROC Curve MH - Texas EDAT- 2009/07/22 09:00 MHDA- 2009/08/14 09:00 CRDT- 2009/07/22 09:00 PHST- 2009/07/22 09:00 [entrez] PHST- 2009/07/22 09:00 [pubmed] PHST- 2009/08/14 09:00 [medline] AID - peds.2008-2949 [pii] AID - 10.1542/peds.2008-2949 [doi] PST - ppublish SO - Pediatrics. 2009 Aug;124(2):573-9. doi: 10.1542/peds.2008-2949. Epub 2009 Jul 20.